BNET Industries
Last Fiscal Year Sales:$95.5M
- Public
- US
Dow Jones Description
This company's strategy is to keep people healthy. Founded in 1984 and headquartered in La Jolla, CA, Stratagene Corporation (NASDAQ: STGN) develops and sells biological products and instruments that are used for life sciences research as well as clinical diagnoses. The company has two key divisions: Research Supplies, which focuses on genetic studies, DNA replication, and cloning; and Clinical Diagnosis, which offers products for allergy and auto-immune testing. 75% of the company's profits come from the Research Supplies division. The company has a partnership with Strand Life Science. It had 2005 revenue of about $130.3 million revenue and has about 450 employees. In April 2006, it launched a new online store, available for available for customers in North America and Europe.
Number of Employees 400
Contact Information
11011 N Torrey Pines Rd
La Jolla, California 92037
(858) 535-5400
Peer Companies
NAICS Code Research and Development in the Social Sciences and Humanities: 541720
Recent Events
-
Reportlinker Adds Biotechnology Reagents - A Global Market Perspective
News & Analysis
Filter by
stratagene corp. - All News and Analysis
TRADE NEWS: Agilent Technologies Launches New Stratagene Gradient Cycler at American Society for Human Genetics Conference
- 2008-11-12
PHILADELPHIA -- Agilent Technologies Inc. (NYSE:A) announced today it has launched a new thermal cycler, the high-performance Stratagene Gradient Cycler. The new instrument broadens Agilent's PCR product line and gives researchers access to a complete workflow solution for end-point PCR from a single supplier. PCR is a fast and...
Stratagene
- 2008-04-30
In April, Stratagene launched a new line of Brilliant II QPCR and QRT-PCR reagents.
TRADE NEWS: Agilent's Stratagene Announces Expanded Line of QPCR, QRT-PCR Reagents at American Association for Cancer Research Conference
- 2008-04-14
First Major Product Launch Since Agilent Acquisition, Brilliant II Enables Greater Sensitivity on Mx Instrumentation
Agilent buys Stratagene and Velocity11
- 2008-01-15
With the purchases this year of Stratagene (see IBO 4/15/07) and Velocity11 (see IBO 11/15/07), and the purchase of Molecular Imaging last year (see IBO 11/30/06), Agilent Technologies expanded the range of analytical technologies it offers and the markets it serves, positioning itself for the fast-growing biotech market and as...
Expanding upon its existing agreement with Stratagene, which Agilent acquired, Strand Life Sciences is helping to develop Agilent's GeneSpring software in order to accelerate upgrades
- 2007-10-15
Expanding upon its existing agreement with Stratagene, which Agilent acquired (see IBO 4/15/07), Strand Life Sciences is helping to develop Agilent's GeneSpring software in order to accelerate upgrades. The first version of GeneSpring GX is set to be released later this year.
In May, Stratagene received a notice of a Writ of Summons
- 2007-08-15
In May, Stratagene received a notice of a Writ of Summons, alleging that its Mx3000P, Mx3005P and Mx4000P instruments and certain reagents infringed Applera's EU Patent No. 872562 B1 related to real-time PCR.
Agilent Technologies Adds Strength to Its Life Science Business With Acquisition of Stratagene
- 2007-06-07
SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced it has completed the acquisition of Stratagene Corp. (NASDAQ: STGN), a leading developer, manufacturer and marketer of specialized life science research and diagnostic products. Agilent expects this strategic acquisition to accelerate its growth in life sciences through a complementary...
Stratagene Reports First Quarter 2007 Revenue and Earnings
- 2007-05-15
LA JOLLA, Calif. -- Stratagene Corporation (Nasdaq:STGN), a developer, manufacturer and marketer of specialized life science research and diagnostic products, today released financial results for the first quarter ended March 31, 2007. Revenues for the first quarter of 2007 were $24.4 million and net income was $1.4 million. Fully...
Agilent Technologies to acquire Stratagene
- 2007-05-01
Agilent Technologies Inc. of Santa Clara, CA will purchase La Jolla, CA-based Stratagene Corp., a provider of life science research and testing products, for about $246.2 million. Agilent makes devices used to test and inspect network components. "We see Stratagene's technology, products and expertise as being highly complementary...
Agilent Techologies to Acquire Stratagene Corporation for 2.57 Times Revenue
- 2007-04-16
The Deal: Agilent Technologies has entered into an agreement to acquire Stratagene Corporation for $10.94 per share, or approximately $245 million, in cash. The deal price represents a premium of more than 28 percent over Stratagene's closing share price prior to the deal announcement. The transaction requires shareholder approval and...
Industry Transcripts by Seeking Alpha
-
51jobs Q3 2009 Earnings Call Transcript
on Nov 23, 2009about JOBS
-
NetEase Q3 2009 Earnings Call Transcript
on Nov 18, 2009about NTES
-
Franklin Covey Co. F4Q09 (Qtr End 08/31/09) Earnings Call Transcript
on Nov 16, 2009about FC
-
Cellcom Israel Ltd. Q3 2009 Earnings Call Transcript
on Nov 16, 2009about CEL
-
URS Corporation Q3 2009 Earnings Call Transcript
on Nov 13, 2009about URS
IndustryTop Rated
